Publication | Closed Access
Neuromyelitis optica following human papillomavirus vaccination
51
Citations
4
References
2012
Year
GynecologyCancer-associated VirusCervical Cancer PreventionHuman Papillomavirus VaccinesVaccine TargetHuman Papillomavirus VaccinationPublic HealthVaccine DevelopmentOphthalmologyCervical HealthVaccine GardasilVirologyOcular PathologyVaccinationCervical Cancer ManagementCervical Cancer ScreeningCervical CancerMultiple SclerosisMedicineVaccine ResearchPrecancerous Lesions
The quadrivalent human papillomavirus (HPV) vaccine Gardasil (Merck & Co., Whitehouse Station, NJ) (qHPV-vac) was recently approved for immunization of adolescent girls to prevent cervical cancer.[1][1] Recently, 5 cases of multiple sclerosis (MS) were reported following qHPV-vac vaccination.[2][2]
| Year | Citations | |
|---|---|---|
2005 | 641 | |
2008 | 157 | |
2008 | 118 | |
2005 | 78 |
Page 1
Page 1